ORIC Pharmaceuticals Inc (ORIC)
9.59
+0.47
(+5.15%)
USD |
NASDAQ |
Nov 22, 16:00
9.60
+0.01
(+0.10%)
After-Hours: 20:00
ORIC Pharmaceuticals Enterprise Value: 404.37M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 404.37M |
| November 21, 2024 | 371.20M |
| November 20, 2024 | 344.39M |
| November 19, 2024 | 354.97M |
| November 18, 2024 | 331.68M |
| November 15, 2024 | 327.45M |
| November 14, 2024 | 350.74M |
| November 13, 2024 | 452.35M |
| November 12, 2024 | 451.65M |
| November 11, 2024 | 454.47M |
| November 08, 2024 | 451.65M |
| November 07, 2024 | 429.77M |
| November 06, 2024 | 454.47M |
| November 05, 2024 | 410.72M |
| November 04, 2024 | 396.61M |
| November 01, 2024 | 391.67M |
| October 31, 2024 | 389.55M |
| October 30, 2024 | 392.30M |
| October 29, 2024 | 362.66M |
| October 28, 2024 | 323.86M |
| October 25, 2024 | 302.69M |
| October 24, 2024 | 323.15M |
| October 23, 2024 | 349.96M |
| October 22, 2024 | 342.20M |
| October 21, 2024 | 371.13M |
| Date | Value |
|---|---|
| October 18, 2024 | 394.42M |
| October 17, 2024 | 373.25M |
| October 16, 2024 | 408.53M |
| October 15, 2024 | 399.35M |
| October 14, 2024 | 400.77M |
| October 11, 2024 | 385.95M |
| October 10, 2024 | 382.42M |
| October 09, 2024 | 381.71M |
| October 08, 2024 | 397.24M |
| October 07, 2024 | 397.94M |
| October 04, 2024 | 405.70M |
| October 03, 2024 | 400.77M |
| October 02, 2024 | 418.41M |
| October 01, 2024 | 436.05M |
| September 30, 2024 | 450.86M |
| September 27, 2024 | 464.87M |
| September 26, 2024 | 444.41M |
| September 25, 2024 | 419.02M |
| September 24, 2024 | 471.93M |
| September 23, 2024 | 470.52M |
| September 20, 2024 | 507.20M |
| September 19, 2024 | 500.85M |
| September 18, 2024 | 466.28M |
| September 17, 2024 | 426.07M |
| September 16, 2024 | 418.31M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-128.03M
Minimum
May 09 2022
1.230B
Maximum
Dec 24 2020
330.03M
Average
302.83M
Median
Apr 19 2024
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
| iBio Inc | 14.05M |
| Theriva Biologics Inc | -12.68M |
| Oragenics Inc | 2.314M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -34.57M |
| Total Expenses (Quarterly) | 38.32M |
| EPS Diluted (Quarterly) | -0.49 |
| Earnings Yield | -18.87% |